Cite
HARVARD Citation
Panés, J. et al. (2021). Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical Trials. Journal of Crohn's and colitis. pp. 1852-1863. [Online].